###begin article-title 0
An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Inflammatory cytokines play a crucial role in coronary artery disease (CAD). We investigated the association between 48 coding and three non-coding single nucleotide polymorphisms (SNPs) from 35 inflammatory genes and the development of CAD, using a large discordant sibship collection (2699 individuals in 891 families).
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
Family-based association tests (FBAT) and conditional logistic regression (CLR) were applied to single SNPs and haplotypes and, in CLR, traditional risk factors of CAD were adjusted for.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1</italic>
###xml 118 120 118 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 146 148 146 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 195 197 195 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 579 581 579 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 624 626 624 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
An association was observed between CAD and a common three-locus haplotype in the interleukin one (IL-1) cluster with P = 0.006 in all CAD cases, P = 0.01 in myocardial infarction (MI) cases and P = 0.0002 in young onset CAD cases (<50 years). The estimated odds ratio (OR) per copy of this haplotype is 1.21 (95% confidence interval [95CI] = 1.04 - 1.40) for CAD; 1.30 (95CI = 1.09 - 1.56) for MI and 1.50 (95CI = 1.22 - 1.86) for young onset CAD. When sex, smoking, hypertension and hypercholesterolaemia were adjusted for, the haplotype effect remained nominally significant (P = 0.05) in young onset CAD cases, more so (P = 0.002) when hypercholesterolaemia was excluded. As many as 82% of individuals affected by CAD had hypercholesterolaemia compared to only 29% of those unaffected, making the two phenotypes difficult to separate.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
Despite the multiple hypotheses tested, the robustness of family design to population confoundings and the consistency with previous findings increase the likelihood of true association. Further investigation using larger data sets is needed in order for this to be confirmed.
###end p 8
###begin p 9
See the related commentary by Keavney:
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1037 1038 1037 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1039 1040 1039 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
Coronary atherosclerosis is predominantly an asymptomatic process that progresses over the course of a lifetime. Arterial inflammation is central to plaque progression and plaque rupture with atherosclerotic lesions established as active sites of inflammation [1]. In particular, cytokines appear to coordinate the development of atherosclerosis leading to the formation of complex atherosclerotic plaques. These, in turn, can trigger acute thromboembolic complications such as myocardial infarction (MI) and the rupture/repair process that promotes the progression of luminal narrowing [2]. Furthermore, those lesions conveying the greatest risk to the individual are characterized by a higher level of inflammation. Coronary atherosclerosis and its complications are a complex disorder resulting from the combined effects of multiple environmental and genetic factors. Whilst most traditional risk factors for coronary artery disease (CAD) are themselves heritable, a family history remains an independent predictor of this condition [1,2]. The aim of this study was to evaluate individual polymorphisms and haplotypes in inflammatory genes for association with an increased predisposition to CAD. In total, 51 single nucleotide polymorphisms (SNPs) were analysed in 35 inflammatory genes in a large cohort of discordant sibships recruited across the UK in the Genetic Risk of Acute Coronary Events (GRACE) study.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Clinical methods
###end title 13
###begin p 14
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 562 565 562 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-1 </sup>
The study was approved by the Multicentre (MREC) and Local Research Ethics Committees (LRECs) throughout the UK. The details of the recruitment process can be found in the Additional File 1. Premature CAD was defined as a validated MI, percutaneous transluminal coronary angioplasty (PTCA), coronary artery bypass surgery (CABG) or angina (exercise test positive or angiogram showing at least one lesion >50%) before the age of 66. Hypercholesterolaemia was considered as either being on lipid lowering therapy or having total cholesterol greater than 4.9 mmol.l-1 for individuals with a previous MI or greater than 5.2 mmol/l for individuals with other affected phenotypes (PTCA, CABG or angina) and unaffected individuals. Hypertension was either being on therapy or a blood pressure greater than 150/90 mmHg.
###end p 14
###begin title 15
Genotyping
###end title 15
###begin p 16
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
###xml 445 449 445 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174; </sup>
###xml 1060 1061 1058 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
Fifty SNPs and one insertion/deletion, mainly located in coding regions of 35 inflammatory genes, were genotyped (48 polymorphisms from coding regions and three from the introns). The primer mix and all other necessary components for the SNP genotyping were provided by Roche Molecular Systems (Pleasanton, USA). Characteristics of the polymorphisms are shown in the Additional File 2. DNA extraction and storage was performed using the PUREGENE(R) DNA extraction kit (available from Gentra Systems, MN, USA). A pooled polymerase chain reaction (PCR) amplified the chosen targets from 50 ng of genomic DNA to produce biotin labelled products. These products were then hybridized with sequence specific oligonucleotide probes immobilized in a linear array. A series of development stages enabled detection of hybridization between probe and PCR product thus allowing identification of genotypes (homozygous wild, homozygous mutant, heterozygote). The processed strip was then scanned and genotypes were assigned by StripScan software (Roche Molecular Systems) [3] providing a semi-automated reading of the data assigning genotypes.
###end p 16
###begin title 17
Statistical analyses
###end title 17
###begin p 18
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 337 338 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 694 695 694 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 981 982 981 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
Family relationships were validated using the Graphical Representation of Relationships (GRR) and RELATIVE programs [4,5] based on the 51 polymorphisms from this study plus 65 additional SNPs (analysis details in the Additional File 3). Allele frequencies were estimated using the program MENDEL which accounts for family relationships [6] and Hardy-Weinberg equilibrium was tested for each SNP using a goodness-of-fit test. The primary analysis was a test of association in presence of linkage between CAD and each individual SNP using the family-based association test (FBAT) [7]. We used the version of this test that employs empirical variance to account for residual familial correlation [8] (program FBAT 2.0.2C, option -e). An additive mode of inheritance was assumed. The analysis was repeated in two subsets of the data: (1) all cases affected with MI and their siblings and (2) all cases of CAD before the age of 50 and their siblings (see details in the Additional File 3). For genes or regions where two or more polymorphisms were in linkage disequilibrium (LD), haplotype analysis was also carried out in FBAT.
###end p 18
###begin p 19
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 619 620 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
The haplotypes showing the highest evidence of association were further analysed using simple conditional logistic regression (CLR) in STATA [9], subsequently adding in clinical covariates. Robust variance was used to account for correlation between family members in CLR [10,11]. Haplotypes were inferred using the program HAPLORE [12]. As parents were not genotyped, there was some uncertainty in haplotype assignment. This uncertainty was accounted for in CLR by using a weighting approach originally designed for unrelated cases and controls [13] and adapted here to family data (see details in the Additional File 3). After identifying a haplotype associated with CAD, we used unconditional logistic regression to assess whether the same haplotype predicts hypercholesterolaemia, the most predominant clinical risk factor for CAD in our dataset.
###end p 19
###begin title 20
Results
###end title 20
###begin title 21
Family structures and effects of clinical risk factors
###end title 21
###begin p 22
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 825 826 825 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 313 320 <span type="species:ncbi:9606">persons</span>
The initial data set consisted of 2870 individuals from 930 families. As a result of relationship checking, a total of 41 families were discarded - mainly because reported siblings were found to be more likely half-siblings. In addition, two families were each split into two, leaving a final sample size of 2699 persons from 891 families. The structure of the families included in this study is detailed in Table 1. The median age of disease onset was 50 years (range 21-66) and 69% of affected individuals had a MI as the index event. The median age of unaffected individuals was 57 years (range 35-85) and intra-family comparisons of ages revealed that over 80% of unaffected siblings had surpassed the age at which their affected siblings had their events. Clinical characteristics of the study sample are shown in Table 2.
###end p 22
###begin p 23
Structure of families included in the study.
###end p 23
###begin p 24
* In this setting, individuals affected after 50 years were considered as unphenotyped
###end p 24
###begin p 25
dagger For this trait coding, individuals free of myocardial infarction (MI) but affected by other forms of coronary artery disease (CAD) were considered unphenotyped.
###end p 25
###begin p 26
Clinical characteristics of the study sample.
###end p 26
###begin p 27
* Univariate conditional logistic regression for binary factors and linear regression clustered by family for body mass index (BMI)
###end p 27
###begin p 28
dagger Odds ratio (OR) and 95% confidence intervals from multivariable conditional logistic regression analysis including all six factors
###end p 28
###begin p 29
SD: standard deviation
###end p 29
###begin p 30
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
Considered individually, each of the traditional risk factors of CAD [male gender, diabetes, hypertension, hypercholesterolaemia, cigarette smoking and body mass index (BMI)] has a highly significant effect on disease risk. When all these factors are included in the model jointly, male gender, hypertension, cigarette smoking and hypercholesterolaemia still show a highly significant effect on CAD, whilst diabetes mellitus has a borderline effect and BMI was not associated with CAD (Table 2).
###end p 30
###begin title 31
Family-based association tests for individual SNPs
###end title 31
###begin p 32
###xml 54 55 54 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 334 337 334 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL9</italic>
###xml 347 349 347 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOS3</italic>
###xml 397 399 397 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 433 435 433 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C5</italic>
###xml 445 447 445 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL4R </italic>
###xml 494 496 494 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 515 517 515 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 539 545 539 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCYA11</italic>
###xml 554 556 554 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 659 662 659 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C5 </italic>
###xml 689 691 689 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 710 712 710 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 800 808 800 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1&#945;</italic>
###xml 825 827 821 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 845 847 841 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
The results of SNP by SNP analysis are shown in Table 3. Results are reported only for SNPs that were in Hardy-Weinberg equilibrium and for which we had at least 50 informative families (the average number of informative families was 345). Associations with CAD significant at 5% level were found for polymorphisms in interleukin 9 [(IL9) C4244T, P = 0.01], nitric oxide synthase 3 [(NOS3) A498G, P = 0.05], complement component 5 [(C5) A2416G, P = 0.04], interleukin 4 receptor [(IL4R T1682C, P = 0.01 and A1902G, P = 0.04] and eotaxin [(SCYA11) G361A, P = 0.04]. In the subsets of MI cases and those with younger CAD onset (<50 years) the associations with C5 (A2416G) remained (MI only P = 0.006; <50 years P = 0.04) and additional significant associations were observed with interleukin 1 alpha (IL1alpha) C549T (MI only P = 0.02; <50 years P = 0.02).
###end p 32
###begin p 33
Tests of association between SNPs and CAD using FBAT.
###end p 33
###begin p 34
###xml 27 28 27 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
* In parenthesis after the P-value: the allele associated with an increased disease risk.
###end p 34
###begin p 35
dagger Number of informative families below 50.
###end p 35
###begin p 36
double dagger Not in Hardy-Weinberg equilibrium.
###end p 36
###begin p 37
MAF, minor allele frequency; SNP, single nucleotide polymorphism; CAD, coronary artery disease.
###end p 37
###begin title 38
Haplotype analysis
###end title 38
###begin p 39
###xml 71 87 71 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1&#945;-IL1&#946;</italic>
###xml 96 97 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 431 435 424 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1 </italic>
###xml 555 557 548 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 577 579 570 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 608 610 601 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 724 726 717 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 765 770 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOS3 </italic>
###xml 887 889 880 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 914 916 907 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 952 954 945 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 976 978 969 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1148 1153 1141 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL4R </italic>
###xml 1157 1164 1150 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCYA11 </italic>
###xml 1171 1172 1164 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
More than one SNP were genotyped within 13 genes and one gene cluster (IL1alpha-IL1beta). Table 4 shows the genes or gene cluster where any haplotype was significantly associated with CAD, CAD before 50 years or MI at the nominal 5% level using FBAT. The LD (measured with D') between adjacent SNPs is also shown along with their physical position from dbSNP build 128. The most significantly associated haplotype was found in the IL1 cluster (CCC haplotype, frequency of 41% in the total sample), which was found at increased frequency in all CAD cases (P = 0.006), MI cases (P = 0.01) and young CAD cases (P = 0.0002), although the overall haplotype effect only reached the 5% significance level in early-onset CAD cases (P = 0.02, with 7 degrees of freedom). In NOS3 gene, there was a significant protective effect of the AT haplotype (frequency 11%) in overall CAD (single haplotype P = 0.009 and overall test P = 0.04) and in MI (single haplotype P = 0.005, overall test P = 0.03). However, there was no evidence of haplotype association in this gene in younger disease onset. Other haplotypes with nominally significant effects were found in IL4R and SCYA11 (Table 4).
###end p 39
###begin p 40
Haplotype association to CAD, CAD before age 50 (CAD50) or MI.
###end p 40
###begin p 41
*Physical position (base pairs) from NCBI dbSNP build 128.
###end p 41
###begin p 42
dagger Absolute value of the linkage disequilibrium (LD) coefficient D' between consecutive single nucleotide polymorphisms (SNPs).
###end p 42
###begin p 43
double dagger Results only shown for haplotypes having a number of informative families >50.
###end p 43
###begin p 44
section signHaplotype frequencies estimated in the total sample.
###end p 44
###begin p 45
+ (-), Haplotype associated with increased (decreased) disease risk; CAD, coronary artery disease; MI, myocardial infarction; SNP, single nucleotide polymorphism.
###end p 45
###begin title 46
IL1 haplotype effect estimation
###end title 46
###begin p 47
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 221 223 221 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 323 325 323 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 384 386 384 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 669 672 669 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 742 744 742 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 792 794 792 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 875 877 875 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 931 934 931 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
Using an additive model with no covariate adjustment in weighted CLR, each copy of IL1-CCC haplotype confers an increase in risk of CAD with estimated odds ratio (OR) of 1.21 [95% confidence interval (95 CI) = 1.04-1.40, P = 0.01] in the total sample. For young-onset cases, the estimated OR was 1.50 (95 CI = 1.22 - 1.86, P = 0.0001) and for MI the OR was 1.30 (95 CI = 1.09 - 1.56, P = 0.003). The overall significance level of all haplotypes (7df) was 0.28 in the whole sample, 0.18 for MI only and 0.02 in the affecteds before age 50. When tested jointly with four clinical covariates (hypercholesterolaemia, hypertension, smoking and sex), the effect of haplotype IL1-CCC on CAD was no longer significant in the whole sample (OR = 1.07, P = 0.57) nor in those affected by MI (OR = 1.26, P = 0.07), but it was nominally significant in younger cases (<50 years OR = 1.39, P = 0.05). No significant interaction was found between IL1-CCC haplotype and any of the covariates.
###end p 47
###begin p 48
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 192 195 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 248 250 248 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 323 325 323 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 646 649 646 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 791 793 791 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 823 826 823 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 992 994 992 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1288 1291 1288 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
The most potent predictor of increased risk of disease in our population was hypercholesterolaemia (see Table 2). When it was excluded from the multivariable analysis, the effect of haplotype IL1-CCC in the whole sample was significant (OR = 1.22, P = 0.05), and was more so in those with younger onset disease (OR = 1.53, P = 0.002, see Table 5). This indicates a possible relationship between the haplotype and hypercholesterolaemia itself. In order to test this, a simple unconditional logistic regression analysis was carried out on the whole study population and stratifying by CAD, using hypercholesterolaemia as the trait of interest with IL1-CCC haplotype as predictor. In the whole dataset, the estimated OR of having hypercholesterolaemia was 1.15 (95 CI = 1.03 - 1.29, unadjusted P = 0.01) per copy of haplotype IL1-CCC. This was comparable to the OR of developing CAD per copy the same haplotype using unconditional logistic regression (OR = 1.21, 95 CI = 1.02 - 1.43, unadjusted P = 0.02). The haplotype effect on hypercholesterolaemia was of the same magnitude in subjects affected and unaffected by CAD, although not significant in these smaller subsets (OR = 1.10, 95 CI = 0.88-1.37 and OR = 1.13, 95 CI = 0.96-1.33, respectively). This result suggests that the haplotype IL1-CCC may increase the risk of CAD through increasing the risk of hypercholesterolaemia, although the high correlation between hypercholesterolaemia and CAD in our study makes this difficult to evaluate.
###end p 48
###begin p 49
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
Joint effects of the IL1-CCC haplotype and other risk factors on CAD.
###end p 49
###begin p 50
* 95% confidence interval (CI)
###end p 50
###begin p 51
CAD, coronary artery disease.
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 514 517 514 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 533 534 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 640 642 640 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 721 723 721 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 749 751 749 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 914 916 914 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 931 932 931 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 1041 1044 1041 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 1145 1148 1145 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
We present here the results of an association analysis of CAD with multiple inflammatory genes in one of the UK's largest discordant sibship studies. This family-based cohort avoids the potential bias of population stratification and admixture that may affect even a well designed case-control study [14]. The haplotype analysis maximized the use of family information and accommodated phase uncertainty. Our strongest finding was a suggested association with a common haplotype in the interleukin 1 gene cluster (IL1-CCC, see Table 4), particularly in those individuals with younger onset CAD. The per-copy OR for CAD was 1.21 (unadjusted P = 0.01), rising to 1.50 in younger affecteds (unadjusted single haplotype test P = 0.0001 and overall test P = 0.02). The effect of this haplotype on early-onset disease risk remained significant after adjusting for covariates other than hypercholesterolaemia (OR = 1.53, P = 0.002, Table 5). However, including hypercholesterolaemia in the model greatly reduced the estimated effect. The effect of IL1-CCC on hypercholesterolaemia was found to be of similar magnitude as on CAD itself, suggesting that IL1-CCC may actually increase the risk to CAD through increasing the risk of hypercholesterolaemia.
###end p 53
###begin p 54
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1 </italic>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RA</italic>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 402 411 402 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1&#946; </italic>
###xml 433 439 430 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RA </italic>
###xml 483 485 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 514 519 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1 </italic>
###xml 609 611 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 770 779 767 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1&#945; </italic>
###xml 783 791 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1&#946; </italic>
###xml 838 840 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 893 898 883 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1 </italic>
###xml 171 174 <span type="species:ncbi:9606">man</span>
###xml 176 180 <span type="species:ncbi:10090|species:ncbi:10095">Mice</span>
###xml 376 380 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
The relationship between hypercholesterolaemia and CAD is well established. At present, no direct evidence of correlation between IL-1 and hypercholesterolaemia exists in man. Mice lacking interleukin-1 receptor antagonist (IL1RA) display significant derangement of cholesterol homeostasis in response to an atherogenic diet [15]. Furthermore, studies in hypercholesterolemic mice suggest that lack of IL-1beta or over-expression of IL1RA can partly protect against atherosclerosis [16]. Accordingly, elevation of IL-1 is consistently observed in individuals with unstable CAD and predicts mortality post MI [17]. The use of HMG-CoA inhibitors (statins), known to reduce lipoprotein levels and risk of cardiovascular events, has been shown to reduce mRNA levels of both IL1alpha and IL1beta in peripheral blood mononuclear cells (PBMCs) [17] providing further evidence of an interplay between IL-1 and hypercholesterolaemia.
###end p 54
###begin p 55
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 19 21 19 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1054 1056 1054 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1153 1155 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
###xml 538 546 <span type="species:ncbi:9606">patients</span>
###xml 1180 1188 <span type="species:ncbi:9606">patients</span>
Ikonomidis et al. [18] have evaluated the immediate and short-term effects of anakinra, a recombinant IL1 receptor antagonist, on coronary flow; left ventricular (LV) and endothelial function and mediators of inflammation. In patients with rheumatoid arthritis and no evidence of CAD/ischaemia, anakinra resulted in both an acute and sustained improvement in left ventricular function, endothelial function and coronary flow reserve with a reduction in IL-6 and endothelin-1, compared to placebo/prednisolone. Relatively small numbers of patients were studied and those with CAD were specifically excluded. It remains unclear, therefore, whether these findings have any relevance to those with CAD/without rheumatoid arthritis. In particular, are the changes in LV and endothelial function reversible when ischaemic in aetiology and are the inflamed joints of active rheumatoid arthritis a prerequisite for anakinra to have an effect? In animal models, acute anakinra administration does appear to reduce cardiomyocyte apoptosis and adverse remodelling [19]. Further clarity is likely to be added by the Medical Research Council funded ILA HEART study [20] evaluating anakinra in patients presenting with a MI.
###end p 55
###begin p 56
###xml 4 12 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1&#946; </italic>
###xml 256 258 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 276 278 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 461 466 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 469 471 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 766 775 763 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1&#946; </italic>
###xml 959 961 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 563 566 <span type="species:ncbi:9606">men</span>
###xml 579 584 <span type="species:ncbi:9606">women</span>
The IL1beta polymorphism C1423T has been investigated previously in relation to CAD, with mixed results. An excess of CC genotypes was reported in affected individuals compared to unaffecteds (22% versus 13%), although this difference was not significant [21]. Another study [22] subsequently found no evidence of difference in allele frequencies on this SNP between subjects with angiographically normal and abnormal coronary arteries. By contrast, Iacoviello et al. [23] found a significantly reduced risk of MI and ischaemic stroke at young age (<45 years for men and <50 for women) in carriers of the T allele after adjustment of the traditional risk factors. They also demonstrated that mononuclear cells in carriers of the T allele produce significantly lower IL-1beta levels than in non-carriers. However, the same T allele was found significantly associated with increased risk of atherogenesis in subclavian arteries in a cohort of elderly Japanese [24].
###end p 56
###begin p 57
###xml 51 59 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1&#946; </italic>
###xml 463 468 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 471 473 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 502 510 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1&#946; </italic>
###xml 656 660 650 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1 </italic>
###xml 777 779 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 798 800 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 827 829 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 915 917 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
In our study, no association was found between the IL1beta C1423T SNP and CAD, but we did detect an association with a haplotype containing this SNP. These results suggest that the SNP itself may not increase the risk of CAD but may be in strong LD with a causal variant, which may also partially explain inconsistencies in results across different studies. It is also possible that it is the haplotype that influences CAD rather than one nucleotide change. Chen et al. [25] showed that SNP alleles in IL1beta have increased transcriptional activity when combined (into haplotypes) and suggested that it may be a common feature of gene regulatory regions. IL1 gene cluster haplotypes have been found associated with many diseases, including schizophrenia and bipolar disorder [26], gastric cancer [27] and psoriatic arthritis [28]. In the case of CAD, age of onset appears to be an important factor (our study and [23]).
###end p 57
###begin p 58
###xml 4 13 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1&#945; </italic>
###xml 17 25 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1&#946; </italic>
###xml 157 159 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 401 405 394 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1 </italic>
###xml 419 421 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 613 617 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1 </italic>
The IL1alpha and IL1beta genes lie on chromosome 2 about 15 Mb centromeric to the linkage peak found in a large UK study of sibling pairs affected with CAD [29]. The evidence for linkage in this region was much stronger in the subset of sibling pairs without hypercholesterolaemia, although when this covariate was included in the analysis the main linkage peak shifted slightly further away from the IL1 gene cluster [30]. It is well known that the highest linkage peak may be at a considerable distance from the disease-causing locus, especially when based on relative pair analyses, so it is possible that the IL1 cluster contributed to the evidence of linkage.
###end p 58
###begin p 59
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOS3 </italic>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 450 452 450 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 550 552 550 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 566 567 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 663 665 663 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 685 687 685 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 726 728 726 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 747 749 747 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 770 771 770 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 868 876 <span type="species:ncbi:9606">patients</span>
Our second interesting finding was in the gene NOS3 on chromosome 7. Many studies have reported an association between the G7002T SNP in this gene (also referred to as 894G/T or Glu298Asp) and a number of diseases including CAD/MI [31,32] and essential hypertension [33,34]. However, most of these studies were based on unrelated case-control designs with a limited size. While our larger study does not confirm the association of this SNP with CAD (P = 0.67, Table 3), we did observe a weak association between CAD and a promoter region SNP (A498G, P = 0.05, Table 3) whilst a haplotype spanning the two SNPs showed a stronger association (single haplotype test P = 0.009 for CAD and P = 0.005 for MI, overall haplotype test P = 0.04 for CAD and P = 0.03 for MI, Table 4). The AT haplotype appears to reduce the risk of CAD and MI, although this was not confirmed in patients affected at younger age. Although the polymorphism G7002T changes the protein sequence (Glu298Asp), its actual functional significance is not well understood [33] and our results suggest again that a haplotype or an untyped SNP may be of relevance.
###end p 59
###begin p 60
###xml 88 102 88 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL9, C5, IL4R </italic>
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCYA11 </italic>
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOS3</italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1 </italic>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOS3 </italic>
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1 </italic>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 839 847 <span type="species:ncbi:9606">patients</span>
Other SNPs or haplotype associations marginally significant in this study were found in IL9, C5, IL4R and SCYA11 (Tables 3 and 4). Their significance was much lower than that of IL1 cluster and NOS3, and given the number of tests performed, they are more likely to be false positives. The IL1 cluster and NOS3 associations may also be due to type 1 errors and do not reach 5% statistical significance if adjusted for the number of tests performed. However, for the IL1 gene cluster, the consistency with prior findings [21,23,24,29,30] and the increased risk observed in younger subjects increase the likelihood that this is a true association, and the family-based design of our study provides reassurance against confounding by population stratification. Further investigation of a denser set of SNPs in this region in larger samples of patients and controls is needed for confirmation.
###end p 60
###begin title 61
Abbreviations
###end title 61
###begin p 62
BMI: body mass index; CABG: coronary artery bypass surgery; CAD: coronary artery disease; CLR: conditional logistic regression; FBAT: family-based association test; LD: linkage disequilibrium; LV: left ventricular; MI: myocardial infarction; PCR: polymerase chain reaction; PTCA: percutaneous transluminal coronary angioplasty; SNP: single nucleotide polymorphism.
###end p 62
###begin title 63
Competing interests
###end title 63
###begin p 64
The authors declare that they have no competing interests.
###end p 64
###begin title 65
Authors' contributions
###end title 65
###begin p 66
The authors' contributions to this study were as follows: design/planning - ASH, NJS, SGB, DTB, AJB and JHB; study set-up - BDB and RAL; SNPs selection/assay production - SC and LS; lab supervision - AJB; statistical analyses - JN and JHB; paper drafting - BDB, JN and JHB; overall supervision - ASH. All the authors read and approved the manuscript.
###end p 66
###begin title 67
Pre-publication history
###end title 67
###begin p 68
The pre-publication history for this paper can be accessed here:
###end p 68
###begin p 69

###end p 69
###begin title 70
Supplementary Material
###end title 70
###begin title 71
Additional file 1
###end title 71
###begin p 72
###xml 36 48 <span type="species:ncbi:9606">participants</span>
Details on the recruitment of study participants.
###end p 72
###begin p 73
Click here for file
###end p 73
###begin title 74
Additional file 2
###end title 74
###begin p 75
List of the polymorphisms analysed in this study (Table S1), with all their characteristics (chromosome region, long and short gene name, common SNP name, rs number, amino acid change).
###end p 75
###begin p 76
Click here for file
###end p 76
###begin title 77
Additional file 3
###end title 77
###begin p 78
Details on the statistical methods in data validation and genetic association testing.
###end p 78
###begin p 79
Click here for file
###end p 79
###begin title 80
Acknowledgements
###end title 80
###begin p 81
This research was supported by the British Heart Foundation (BHF) and the UK National Health Services Research and Development (NHS R&D). We thank all the families who participated in the study, as well as the staff in hospitals and general practices who helped in the collection of samples and the validation of medical records.
###end p 81
###begin article-title 82
Atherosclerosis-an inflammatory disease
###end article-title 82
###begin article-title 83
Genetics of atherosclerosis
###end article-title 83
###begin article-title 84
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOS2A </italic>
Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis
###end article-title 84
###begin article-title 85
GRR: graphical representation of relationship errors
###end article-title 85
###begin article-title 86
Relationship estimation in affected sib pair analysis of late-onset diseases
###end article-title 86
###begin article-title 87
Allele frequency estimation from data on relatives
###end article-title 87
###begin article-title 88
A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information
###end article-title 88
###begin article-title 89
Family-based tests of association in presence of linkage
###end article-title 89
###begin article-title 90
Stata Statistical Software: Release 9. TX: StataCorp LP
###end article-title 90
###begin article-title 91
Testing linkage disequilibrium in sibships
###end article-title 91
###begin article-title 92
Power, validity, bias and robustness of family-based association analysis methods in the presence of linkage for late onset diseases
###end article-title 92
###begin article-title 93
HAPLORE: a program for haplotype reconstruction in general pedigrees without recombination
###end article-title 93
###begin article-title 94
Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals
###end article-title 94
###begin article-title 95
Assessing the impact of population stratification on genetic association studies
###end article-title 95
###begin article-title 96
###xml 124 128 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice
###end article-title 96
###begin article-title 97
###xml 87 91 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Lack of interleukin-1 beta decreases the severity of atherosclerosis in ApoE-deficient mice
###end article-title 97
###begin article-title 98
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of hmg-coa reductase inhibitors
###end article-title 98
###begin article-title 99
###xml 91 99 <span type="species:ncbi:9606">patients</span>
Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis
###end article-title 99
###begin article-title 100
###xml 24 29 <span type="species:ncbi:9606">human</span>
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction
###end article-title 100
###begin article-title 101
Investigation of the effect of interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (the MRC-ILA-HEART Study)
###end article-title 101
###begin article-title 102
###xml 106 127 106 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia pneumoniae </italic>
###xml 106 126 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection
###end article-title 102
###begin article-title 103
Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease
###end article-title 103
###begin article-title 104
Polymorphisms of the interleukin-1 beta gene affect the risk of myocardial infarction and ischaemic stroke at young age and the response of mononuclear cells to stimulation in vitro
###end article-title 104
###begin article-title 105
Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases
###end article-title 105
###begin article-title 106
###xml 39 44 <span type="species:ncbi:9606">human</span>
Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context
###end article-title 106
###begin article-title 107
Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder
###end article-title 107
###begin article-title 108
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
###end article-title 108
###begin article-title 109
Association between the interleukin-1 family gene cluster and psoriatic arthritis
###end article-title 109
###begin article-title 110
A genomewide linkage study of 1,933 families affected by premature coronary artery disease: the British Heart Foundation (BHF) family heart study
###end article-title 110
###begin article-title 111
Enhanced linkage of a locus on chromosome 2 to premature coronary artery disease in the absence of hypercholesterolaemia
###end article-title 111
###begin article-title 112
Association of the missense glu298asp variant of the endothelial nitric oxide synthase gene with myocardial infarction
###end article-title 112
###begin article-title 113
A common variant of the endothelial nitric oxide synthase (glu298->asp) is a major risk factor for coronary artery disease in the UK
###end article-title 113
###begin article-title 114
Association of the glu298asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy
###end article-title 114
###begin article-title 115
Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in Northern Japan
###end article-title 115

